One report, two million providers

With the importance of equity, inclusion, diversity and belonging taking center stage in the national debate on healthcare, HealthVerity realized that its real-world data (RWD) ecosystem was ideally suited to respond to the challenge. The HealthVerity Provider Diversity and Diagnosis Index (PDI) Masterset is the only nationally syndicated report that leverages medical, pharmacy and consumer data to compute the racial diversity of patients for over 2 million healthcare providers, all in a HIPAA-compliant manner. The PDI has become the definitive guide for a wide range of diversity-challenged endeavors, such as clinical trial investigator recruiting and health plan network building.

Broaden choices for clinical trial investigators

Instantly assess the demographic composition of a healthcare provider’s patient population, including race, age, gender, income and payer type to ascertain if the physician would make an optimal investigator for your clinical trial. PDI also provides diagnosis codes so you know the demographic composition of patients being treated for the specific disease state you’re studying.

Meet FDA guidance

Ensure alignment with the latest guidance from the FDA regarding the need to increase participation from underrepresented racial and ethnic populations in clinical trials.

Diversify provider networks

Determine if the providers in your network best reflect the diversity of the areas they serve by comparing Census data for geographic areas of key physician specialties with their computed demographic mix.

Experience how you can ensure equity


Sync diversity

Dummy Image

Synchronizing diversity in clinical trials

This informative webinar explores enhancements to the 2023 PDI, including age, gender, income, payer type and diagnosis code, creating a HIPAA-compliant guide for discovering optimal clinical investigators treating more diverse populations.

Dummy Image

HealthVerity releases the Provider Diversity Index 2023 edition to increase diversity in clinical trials

Announcing the release of the PDI 2023 edition with breakthrough enhancements that help pharmaceutical manufacturers to prioritize physicians who are treating patients more reflective of the populations impacted by the conditions being studied.

Dummy Image

Sync up diversity in clinical trials

Clinical trials are out of sync, rarely including participants in ethnic proportion to those actually diagnosed with the condition being studied, creating gaps in knowledge that impact outcomes.